Potentiation of L-dopa-induced behavioral excitement by histamine H1-receptor antagonists in mice

Japanese Journal of Pharmacology

Volumn 71, Issue 1, 1996, Pages 81-84

  Sato, Tomoaki ^a   Suemaru, Katsuya ^b   Matsunaga, Kazuhisa ^a   Hamaoka, Sumiko ^b   Gomita, Yutaka ^b   Oishi, Ryozo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Dopamine uptake; Histamine H1 receptor antagonist; L dopa

Indexed keywords

CHLORCYCLIZINE; CHLORPHENIRAMINE; DIPHENHYDRAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LEVODOPA; MEPYRAMINE; PARGYLINE; PIMOZIDE; TRIPELENNAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030013452     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.71.81     Document Type: Article

References (12)

1. Lidbrink P, Jonsson G and Fuxe K: The effect of imipramine like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology 10, 521-536 (1971)
2. Brown PA and Vernikos J: Antihistamine effect on synaptosomal uptake of serotonin, norepinephrine and dopamine. Eur J Pharmacol 65, 89-92 (1980)
3. Tuomisto J and Tuomisto L: Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes. Med Biol 58, 33-37 (1980)
4. 1-receptor antagonists on monoamine metabolism in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol 343, 185-189 (1991)
5. 1-preceptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol 349, 140-144 (1994)
6. Plotnikoff N, Will F, Evans A and Meekma P: PS-2747: A new antidepressant agent. Arch Int Pharmacodyn Ther 195, 330-342 (1972)
7. Coyle JT and Snyder SH: Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science 166, 899-901 (1969)
8. Kubo N, Shirakawa O, Kuno T and Tanaka C: Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay. Jpn J Pharmacol 43, 277-282 (1987)
9. Suzuki T, Masukawa Y and Misawa M: Drug interactions in the reinforcing effects of over-the-counter cough syrups. Psychopharmacology (Berlin) 102, 438-442 (1990)
10. Suzuki T, Masukawa Y, Shiozaki Y and Misawa M: Potentiation of pentazocine conditioned place preference by tripelennamine in rats. Psychopharmacology (Berlin) 105, 9-12 (1991)
11. Showalter CV and Moore L: Abuse of pentazocine and tripelennamine. JAMA 239, 1610-1612 (1978)
12. Butch AJ, Yokel RA, Sigell LT, Hanenson IB and Nelson ED: Abuse and pulmonary complication of injecting pentazocine and tripelennamine in tablets. Clin Toxicol 14, 301-306 (1979)